Tag: EuroPCR 2018

“Wait-and-see” is not an option with the new device regulations

The new EU Medical Device Regulation (MDR) was officially published on 5 May 2017 and entered into force 20 days later, on 25 May...

EuroPCR 2018: Study indicates “almost perfect agreement” between CT angiography and...

A new study, SYNTAX III REVOLUTION, has found heart teams using computed tomography (CT) angiography to decide between percutaneous coronary intervention (PCI) and coronary...

EuroPCR 2018: Both immediate and delayed approaches seem to work for...

A new study indicates that a delayed approach in patients with transient ST-segment elevation myocardial infarction (STEMI) is associated with similar safety and efficacy...

EuroPCR 2018: Will SPYRAL-ON change my practice?

In this PCR video, David E Kandzari (Department of Interventional Cardiology, Piedmont Heart Institute, Atlanta, USA) speaks to Atul Pathak (National Institute of Health and...

EuroPCR 2018: Low incidence of cardiovascular mortality with Centera self-expanding valve...

Hermann Reichenspurner (Departments of Cardiovascular Surgery and General and Interventional Cardiology, University Heart Center, Hamburg, Germany) at EuroPCR (22 May—25 May, Paris, France) reported...

EuroPCR 2018: No significant difference in bioprosthetic valve dysfunction between surgical...

The NOTION trial (Nordic aortic valve intervention) was the first comparison of surgical and transcatheter aortic valve implantation (TAVI) in patients at lower surgical...

EuroPCR 2018: Real-world data confirm trial outcomes for Sapien 3

Thirty-day data presented at EuroPCR (22 May—25 May, Paris, France) show consistently positive patient outcomes for patients undergoing transcatheter aortic valve implantation (TAVI) with...

EuroPCR 2018: FFR-guided PCI reduces spontaneous myocardial infarction

Five-year data from FAME (Fractional Flow Reserve vs. Angioplasty for Multivessel Evaluation) 2 show that patients with stable disease who undergo percutaneous coronary intervention...

EuroPCR 2018: New ORBITA analysis finds iFR/FFR values do not predict...

New data from the ORBITA trial indicates percutaneous coronary intervention (PCI) does not significantly reduce exercise time compared with a sham procedure in patients...

EuroPCR 2018: Data confirms long-term safety and efficacy of Angiolite drug-eluting...

At EuroPCR (22 May–25 May, Paris, France), the 12-month results of the ANGIOLITE trial were presented for the first time by J Moreu Burgos....

EuroPCR 2018: PiCSO therapy reduces infarct size in acute myocardial infarction...

The clinical results from the OxAMI-PiCSO study—published in EuroIntervention and presented at EuroPCR (22 May–25 May, Paris, France)—provide further evidence for the use of the...

EuroPCR 2018: Interim nine-month results for Magnitude presented

Amaranth Medical provided an update on its sirolimus-eluting bioresorbable scaffold products during a satellite symposium at EuroPCR (22 May—25 May, Paris, France), including Magnitude...

Positive clinical results from eCOBRA study

CeloNova BioSciences has announced one-year clinical trial results from the eCOBRA post-market study of its Cobra PzF nano-coated stent. The clinical trial results demonstrated...

EuroPCR 2018: One- to two-year landmark analysis shows significantly lower target...

Two-year outcome data from the BIO-RESORT randomised controlled trial, which were presented in a late-breaking clinical trials session by Marlies M Kok (Thoraxcentrum Twente,...

EuroPCR 2018: DIAB8 randomised study to compare Cre8 Evo with everolimus-eluting...

Alvimedica unveiled the details of the Diab8 study—the first diabetic drug-eluting stent randomised trial—during EuroPCR (22–25 May, Paris, France). Diab8 is a 55-centre, 3,040-patient...

EuroPCR 2018: Further evidence for safety and efficacy of Magmaris bioresorbable...

Data presented during EuroPCR (22 May – 25 May, Paris, France) provide further evidence on its continued safety and efficacy, also in a more complex...

EuroPCR 2018: Positive data for renal denervation reignites interest in...

After two studies indicated that renal denervation lowers blood pressure both with and without antihypertensive drugs, Felix Mahfoud (Klinik für Innere Medizin III, Saarland...

EuroPCR 2018: Two studies provide support for HeartFlow Analysis

New data from the PACIFIC study presented at EuroPCR (22 May – 25 May, Paris, France) showed that the HeartFlow Analysis had the highest...

EuroPCR 2018: Boston Scientific outlines its key presentations

Boston Scientific Corporation has revealed its schedule of key presentations—including two late-breaking clinical trials—that will be featured at the 2018 EuroPCR (22–25 May, Paris,...

EuroPCR 2018: First-in-human study of Leaflex Performer for aortic stenosis initiated

Pi-Cardia has recently started its first-in-human study with its Leaflex Performer catheter system. According to a press release, the Leaflex Performer is a transfemoral catheter...

New trial of Symplicity Spyral approved

Medtronic has announced US FDA approval to begin an investigational device exemption (IDE) pivotal trial to evaluate its Symplicity Spyral renal denervation system in...